Mori et al. [54] published an extensive review on other blood-based, possible predictors of mortality after radical cystectomy, with thirty-two studies including 22,224 patients that were found eligible for inclusion into the meta-analysis: Several preoperative biomarkers were significantly associated with cancer-specific survival: Three are inflammatory markers: increased neutrophil to lymphocyte ratio (HR: 1.20, 95% CI 1.11–1.29), increased levels of C-reactive protein (HR: 1.44, 95% CI 1.26–1.66) and the increase in white blood cell (WBC) count (HR: 1.05, 95% CI 1.02–1.07). This evidence concerns the gene CRP and cancer.